Breath analysis by ultra-sensitive broadband laser spectroscopy detects SARS-CoV-2 infection

Author:

Liang QizhongORCID,Chan Ya-Chu,Toscano JuttaORCID,Bjorkman Kristen KORCID,Leinwand Leslie AORCID,Parker Roy,Nozik Eva S,Nesbitt David J,Ye JunORCID

Abstract

Abstract Rapid testing is essential to fighting pandemics such as coronavirus disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Exhaled human breath contains multiple volatile molecules providing powerful potential for non-invasive diagnosis of diverse medical conditions. We investigated breath detection of SARS-CoV-2 infection using cavity-enhanced direct frequency comb spectroscopy (CE-DFCS), a state-of-the-art laser spectroscopic technique capable of a real-time massive collection of broadband molecular absorption features at ro-vibrational quantum state resolution and at parts-per-trillion volume detection sensitivity. Using a total of 170 individual breath samples (83 positive and 87 negative with SARS-CoV-2 based on reverse transcription polymerase chain reaction tests), we report excellent discrimination capability for SARS-CoV-2 infection with an area under the receiver-operating-characteristics curve of 0.849(4). Our results support the development of CE-DFCS as an alternative, rapid, non-invasive test for COVID-19 and highlight its remarkable potential for optical diagnoses of diverse biological conditions and disease states.

Funder

DOE

NIST

AFOSR

NSF

NIH

Publisher

IOP Publishing

Subject

Pulmonary and Respiratory Medicine

Reference52 articles.

1. Coronavirus Pandemic (COVID-19);Ritchie;Our World in Data,2020

2. Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19,2020

3. Artificial intelligence–enabled rapid diagnosis of patients with COVID-19;Mei;Nat. Med.,2020

4. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening;Larremore;Sci. Adv.,2021

5. Molnupiravir and Nirmatrelvir-Ritonavir: oral COVID antiviral drugs;Saravolatz;Clin. Infect. Dis.,2022

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3